Cross Scale SCD Related Lipid Remodelling and Variable Triglyceride Zonation in Human Steatotic Liver Disease
Liver International Communications · 2026-12 · 7 (4)
DOI: 10.1002/lci2.70065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International Communications, online erschienen am 15.11.2026. Verfasst von Beibei Huang und 1 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Stearoyl‐CoA desaturase (SCD) links saturated to monounsaturated fatty acid metabolism with triglyceride synthesis. Whether circulating SCD‐related fatty acid patterns, hepatic SCD expression, lobular SCD organisation and downstream triglyceride distribution are concordant in human steatotic liver disease is unclear.
Methods
We analysed NHANES 2021–2023, two liver biopsy cohorts and human spatial RNA and protein data. Matched cell and nuclear datasets and liver Xenium measurements examined differences in SCD localisation. Paired plasma and liver lipidomics and human MASLD spatial multiomics assessed fatty acid correspondence and the spatial distribution of a selected triglyceride.
Results
Among 3498 adults in the fully adjusted NHANES analysis, each weighted standard deviation increase in log‐transformed red blood cell 16:1n‐7/16:0 was associated with 8.48 dB/m higher CAP (95% confidence interval 5.82–11.14; p < 0.001) and higher odds of CAP ≥ 275 dB/m (odds ratio 1.49, 95% confidence interval 1.37–1.61; p < 0.001). Hepatic SCD expression was higher in both biopsy cohorts, with different disease‐stage patterns. Spatial and nuclear SCD patterns differed within four donors. In an independent 16‐donor compartment analysis, nuclear SCD retained the whole‐cell contrast direction in 15 donors. Plasma and hepatic fatty acid ratios were correlated, whereas the selected triglyceride showed variable anatomical and local SCD associations in nine MASL/MASH samples.
Conclusion
Circulating SCD‐related fatty acid patterns and hepatic SCD expression accompany steatosis, while spatial SCD and triglyceride organisation vary across measurement contexts.
Zitieren
APA
Huang, B., & Xu, H. (2026). Cross Scale SCD Related Lipid Remodelling and Variable Triglyceride Zonation in Human Steatotic Liver Disease. Liver International Communications, 7(4). https://doi.org/10.1002/lci2.70065
Vancouver
Huang B, Xu H. Cross Scale SCD Related Lipid Remodelling and Variable Triglyceride Zonation in Human Steatotic Liver Disease. Liver International Communications. 2026;7(4). doi:10.1002/lci2.70065
BibTeX
@article{Huang2026,
author = {Huang, Beibei and Xu, Hang},
title = {Cross Scale SCD Related Lipid Remodelling and Variable Triglyceride Zonation in Human Steatotic Liver Disease},
journal = {Liver International Communications},
year = {2026},
volume = {7},
number = {4},
doi = {10.1002/lci2.70065}
}
EUVIMED